Farah Jivraj is currently the Head of Market Access and stakeholder relations for Biogen Canada. After receiving her Pharmacy degree and M.Sc. in Health Economics & Health Policy degree from England, Farah worked in South East Asia training Government officials on Health Economics and Policy. Over the last 20 years, Farah has had significant experience in the Health industry, at large Pharmaceutical companies, such as Sanofi Genzyme and Janssen, as well as Biotechnology companies in leadership positions in Medical Affairs, Government & Access and Health Economics. Farah has provided strong leadership and strategic direction on Health Policy and access related functions working with Governments and Private Insurers. She has built relationships with Health Technology Assessment experts to create an optimal Canadian environment to adopt innovative therapies.
Beyond the office, Farah is an active member of her community. She was the Vice Chair for Focus Humanitarian Assistance Canada that helps communities prepare for national and manmade disasters and continues to volunteer in the community. Farah has presented at various leadership conferences on global drug initiatives and cost effectiveness. Farah has one son and resides in the Queen west area of Toronto.
Day 1: Oct 6, 2020
Strategies for Managing Through the Adjusted Timeline and Transition to Implementation of the New Pricing Guidelines
Given the uncertainties created by the change in implementation date to the new pricing guidelines, navigating the marketplace will be challenging. Fine-tune your pricing strategy as the new guidelines gain clarity. Take away a road map to help your organization with:
- Strategies for product positioning and pricing
- Insights about determining factors on whether medicines will be classified as Category I or Category II
- Understanding what impact the current consultation process could have on the final guidelines and on your organization
Gain clarity on how to align your pricing strategies with the new PMPRB pricing guidelines as they emerge under the new implementation timeline
Day 2: Oct 7, 2020
Day 3: Oct 8, 2020